Goldman Says Value, Not Cyclicals, Would Rally Most on Vaccine
The Goldman Sachs Group Inc. logo is displayed in the reception area of one of the Goldman Sachs offices, in Singapore. (Photographer: Nicky Loh/Bloomberg)

Goldman Says Value, Not Cyclicals, Would Rally Most on Vaccine

(Bloomberg) -- Value shares are a better way to bet on a Covid-19 vaccine than cyclical stocks, even though the latter have gained favor for capturing the trade, according to Goldman Sachs Group Inc.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.